D. E. Shaw Co., a fund founded by billionaire quant David Shaw, has disclosed its position in AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) in a recent filing with the Securities and Exchange Commission. According to the 13G filing, D. E. Shaw owns 1.73 million shares of AMAG, which represent 5.0% of the company’s outstanding stock. The position is passive by nature.
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| D. E. Shaw Co., L.P. 13-3695715 | 1,729,526 | 1,735,509 | 1,735,509 | 5.0% | ||
| David E. Shaw | 1,729,526 | 1,735,509 | 1,735,509 | 5.0% |
Page 1 of 6 SEC Filing
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
AMAG Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value $0.01
(Title of Class of Securities)
00163U106
(CUSIP Number)
January 4, 2016
(Date of Event Which Requires Filing of this
Statement)
Check the following box to designate the rule pursuant to which
the Schedule is filed:
| ¨ | Rule 13d-1(b) |
| x | Rule 13d-1(c) |
| ¨ | Rule 13d-1(d) |
*The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or
otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
